Navigation Links
China Kangtai Participates in 2007 China National Sugar and Wine Products Trade Fair
Date:10/19/2007

carotene, vitamin C, vitamin E, vitamin K1, vitamin B1, vitamin B2, vitamin B6, vitamin B12, smoke acid, folacin, calcium, phosphorus, iron, potassium, sodium, magnesium, manganese, copper, zinc, iodine, and selenium. Various cactus products have been shown to provide health benefits and have been used to treat a variety of health issues including, diabetes, adiposity, constipation, cholesterol, high blood pressure, low immunity, and various skin disorders.

China Kangtai owns nearly 400 acres of farmland and grows three species of Mexican cacti and some of the Company's own cloned species. The Company owns an R & D institute that has successfully produced 31 product patents, 15 of which have already been approved. It currently produces and sells four cactus-based product categories: nutraceuticals, which are health and wellness dietary supplements; beverages, including juice, teas, beer, wine, and spirits; packaged foods, such as noodles, biscuits and pickles; and raw and intermediate cactus materials. There are about 36 existing products under these four categories.

Jinjiang Wang, Chief Executive Officer of China Kangtai Cactus Biotech commented, ''Cactus-based products are well received by the market in China and show huge growth potential. China Kangtai will continue to develop new products to meet the demand of the consumers, while penetrating the markets with its existing products.''

Wang concluded, ''Our Company remains focused on the quality and functionality of our products that deliver various health benefits to consumers. These new products will contribute positively to the Company's 2007 performance and beyond, and accelerate its revenue and profit growth. With 15 product patents and 16 pending approval, China Kangtai is the dominant player in the cactus-based consumer product sector."

About China Kangtai Cactus Bio-Tech Inc.

China Kangtai Cactus Bio-Tech, Inc. is market-leading cactus grower and producer of cactus-related p
'/>"/>

SOURCE China Kangtai Cactus Bio-tech, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. China tells officials not to hide SARS damage
2. China reports declining number of SARS Cases
3. China says patient may have SARS
4. 15 Anti-SARS Drugs Identified By China-Europe Team of Researchers
5. Adverse Effects Associated with Unauthorised Hepatitis A Vaccine in China
6. Pig Bacterium (Streptococcus suis) Kills 24 In China
7. Watch Out! Pollution hazard from E-waste recycling in India & China
8. French Fries In Cancer Controversy In China
9. China To Distribute Free Condoms To Combat AIDS/HIV
10. HIV Cases Steadily Increasing In China With The Toll Over 1.26 Lakh
11. India And China Discuss Import Of Encephalitis Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 2Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 3Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 4Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 5Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 6Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 7Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 8Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 9Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 2Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 3Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 4Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 5Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 6Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 7Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 8Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 9Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 2Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 3Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 4Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 5Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 6Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 7Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 8Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 9Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 10Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 11Nearly 9 in 10 Seniors Satisfied With Medigap 48743 1Nearly 9 in 10 Seniors Satisfied With Medigap 48743 2Nearly 9 in 10 Seniors Satisfied With Medigap 48743 3A Robot That Reads Your Mind 3F 48740 1A Robot That Reads Your Mind 3F 48740 2The Stress of Sudden Fame Made Anxiety Attacks Headline News 48736 1The Stress of Sudden Fame Made Anxiety Attacks Headline News 48736 2
Other Medicine Technology:New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy 2New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy 3New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy 4New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy 5New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy 6New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy 7U. of Md. Researchers to Develop Devices to Revolutionize Drug Research 2U. of Md. Researchers to Develop Devices to Revolutionize Drug Research 3U. of Md. Researchers to Develop Devices to Revolutionize Drug Research 4U. of Md. Researchers to Develop Devices to Revolutionize Drug Research 5